Ferguson Toby
SEC CIK 2015616 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | Chief Medical Off | 183.9K | — | $105.5K | 5 | 2024-04-01 | 2026-02-06 |
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-10 | 2026-02-06 | VYGR | Voyager Therapeutics, Inc. | Ferguson Toby | Chief Medical Off | A - Grant | $0.00 | +45.0K | 183.9K | +32% | $0 |
| 2025-08-20 | 2025-08-18 | VYGR | Voyager Therapeutics, Inc. | Ferguson Toby | Chief Medical Off | S - Sale | $3.73 | -19.0K | 138.9K | -12% | -$70.9K | |
| 2025-04-04 | 2025-04-02 | VYGR | Voyager Therapeutics, Inc. | Ferguson Toby | Chief Medical Off | S - Sale | $3.43 | -10.1K | 157.9K | -6% | -$34.6K | |
| D | 2025-02-24 | 2025-02-21 | VYGR | Voyager Therapeutics, Inc. | Ferguson Toby | Chief Medical Off | A - Grant | $0.00 | +63.0K | 168.0K | +60% | $0 |
| 2024-04-03 | 2024-04-01 | VYGR | Voyager Therapeutics, Inc. | Ferguson Toby | Chief Medical Off | A - Grant | $0.00 | +105.0K | 105.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations